Antisense to Apoptosis Inhibitors Facilitates Chemotherapy and TRAIL-Induced Death Signaling

Annals of the New York Academy of Sciences

Volumn 1002, Issue , 2003, Pages 90-94

  Zangemeister Wittke, Uwe ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antisense; Apoptosis; Bcl 2; Bcl xL; Chemotherapy; siRNA; TRAIL

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA FRAGMENT; DOXORUBICIN; PACLITAXEL; PROTEIN BCL 2; PROTEIN BCL XL; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DNA FLANKING REGION; DNA MODIFICATION; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; GENE TECHNOLOGY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALIA;

EID: 1342332363     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1281.019     Document Type: Conference Paper

References (8)

1. HANAHAN, D. & R. A. WEINBERG. 2000. The hallmarks of cancer. Cell 100: 57-70.
2. JANSEN, B. & U. ZANGEMEISTER-WITTKE. 2002. Antisense therapy of cancer - the time of truth. Lancet Oncol. 3: 672-683.
3. VICKERS, T.A., S. KOO, C.F. BENNETT, et al. 2003. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278: 7108-7118.
4. MONIA, B.P., E.A. LESNIK, C. GONZALEZ, et al. 1993. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268: 14514-14522.
5. SIMÕES-WÜST, A., T. SCHÜRPF, J. HALL, et al. 2002. Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. Breast Cancer Res. Treat. 76: 157-166.
6. GAUTSCHI, O., S. TSCHOPP, S.H. LEECH, et al. 2001. Activity of a novel bcl-2/bcl-xL bispecific antisense oligonucleotide against tumors of diverse histological origins. J. Natl. Cancer Inst. 93: 463-471.
7. WAHLESTEDT, C., P. SALMI, L. GOOD, et al. 2000. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97: 5633-5638.
8. OLIE, R.A., A.P. SIMÕES-WÜST, B. BAUMANN, et al. 2000. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60: 2805-2809.